Validation of a 4-item Negative Symptom Assessment (NSA-4): A short, practical clinical tool for the assessment of negative symptoms in schizophrenia

International Journal of Methods in Psychiatric Research

Volumn 20, Issue 2, 2011, Pages

  Alphs, Larry ^a   Morlock, Robert ^a   Coon, Cheryl ^b   Cazorla, Pilar ^c   Szegedi, Armin ^c   Panagides, John ^c  

^a PFIZER INC   (United States)

^b RTI HEALTH SOLUTIONS   (United States)

^c Schering Plough   (United States)

Author keywords

Negative symptoms; NSA 4; Schizophrenia

Indexed keywords

ADULT; ARTICLE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK; SCHIZOPHRENIA;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 79956356328     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.339     Document Type: Article

References (15)

1. Addington D., Addington J., Schissel B. (1990) A depression rating scale for schizophrenics. Schizophrenia Research, 3(4), 247-251.
2. Axelrod B.N., Goldman R.S., Alphs L.D. (1993) Validation of the 16-item Negative Symptom Assessment. Journal of Psychiatric Research, 27(3), 253-258.
3. Buchanan R.W. (2007) Persistent negative symptoms in schizophrenia: An overview. Schizophrenia Bulletin, 33(4), 1013-1022.
4. Cohen J. (1992) A power primer. Psychological Bulletin, 112(1), 155-159.
5. Cronbach J. (1951) Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297-334.
6. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33(6), 766-771.
7. Guy W. (1976) Clinical global impressions. In Guy W. (ed.) ECDEU Assessment Manual for Psychopharmacology, pp. 217-222, Washington, DC, US Department of Health, Education, and Welfare.
8. Heinrichs D.W., Hanlon T.E., Carpenter W.T. Jr (1984) The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3), 388-398.
9. Kay S.R., Fiszbein A., Opler L.A. (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276.
10. Marder S.R., Davis J.M., Chouinard G. (1997) The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. Journal of Clinical Psychiatry, 58, 538-546.
11. Nunnally J.C., Bernstein I.H. (1994) Psychometric Theory, New York, McGraw-Hill.
12. Schuck P. (2004) Assessing reproducibility for interval data in health-related quality of life questionnaires: Which coefficient should be used? Quality of Life Research, 13, 571-586.
13. Strauss J.S., Carpenter W.T. Jr (1977) Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Archives of General Psychiatry, 34, 159-163.
14. Streiner D.L., Norman G.R. (1995) Health Measurement Scales: A Practical Guide to Their Development and Use, New York, Oxford University Press.
15. Voruganti L.N., Awad A.G. (2002) Personal evaluation of transitions in treatment (PETiT): A scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophrenia Research, 56, 37-46.